Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Post Operative Continuous Active Combination Sex Steroids for the Prevention of Recurrent Endometrioma Formation

This study has been withdrawn prior to enrollment.
(Poor enrollment)
Sponsor:
Information provided by (Responsible Party):
University of Oklahoma
ClinicalTrials.gov Identifier:
NCT00999479
First received: October 20, 2009
Last updated: December 9, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: October 2011
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)